JP2013521485A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013521485A5 JP2013521485A5 JP2012555389A JP2012555389A JP2013521485A5 JP 2013521485 A5 JP2013521485 A5 JP 2013521485A5 JP 2012555389 A JP2012555389 A JP 2012555389A JP 2012555389 A JP2012555389 A JP 2012555389A JP 2013521485 A5 JP2013521485 A5 JP 2013521485A5
- Authority
- JP
- Japan
- Prior art keywords
- value
- polypeptide
- interest
- gradient
- mobile phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10155023.4 | 2010-03-01 | ||
| EP10155023 | 2010-03-01 | ||
| US30964210P | 2010-03-02 | 2010-03-02 | |
| US61/309,642 | 2010-03-02 | ||
| PCT/EP2011/052964 WO2011107447A1 (en) | 2010-03-01 | 2011-03-01 | Preparative rp-hplc method for purifying peptides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013521485A JP2013521485A (ja) | 2013-06-10 |
| JP2013521485A5 true JP2013521485A5 (enExample) | 2014-04-17 |
| JP5992836B2 JP5992836B2 (ja) | 2016-09-14 |
Family
ID=42727392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012555389A Expired - Fee Related JP5992836B2 (ja) | 2010-03-01 | 2011-03-01 | ペプチドを精製するための分取ｒｐ−ｈｐｌｃ法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US9422330B2 (enExample) |
| EP (1) | EP2542565A1 (enExample) |
| JP (1) | JP5992836B2 (enExample) |
| CN (1) | CN102770440A (enExample) |
| WO (1) | WO2011107447A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2012313045A1 (en) * | 2011-09-22 | 2014-04-10 | Hochschule Ostwestfalen-Lippe | Method for producing peptide fractions and use thereof |
| US8921113B2 (en) | 2012-12-21 | 2014-12-30 | Dionex Corporation | Buffer kit and method of generating a linear pH gradient |
| US9724622B2 (en) | 2013-01-29 | 2017-08-08 | Neuland Health Sciences Private Limited | Purification of organic compounds using surrogate stationary phases on reversed phase columns |
| EP2976331B1 (en) | 2013-03-21 | 2017-03-01 | Sanofi-Aventis Deutschland GmbH | Synthesis of hydantoin containing peptide products |
| MX365465B (es) | 2013-03-21 | 2019-06-04 | Sanofi Aventis Deutschland | Sintesis de productos peptidicos que contienen imida ciclica. |
| CA2924821A1 (en) * | 2013-09-20 | 2015-03-26 | Davuluri, Ramamohan Rao | Purification of organic compounds by surfactant mediated preparative hplc |
| CN105223296B (zh) * | 2015-10-16 | 2017-12-05 | 江苏开元药业有限公司 | 一类多肽的纯化方法 |
| EP3433268B1 (en) | 2016-03-23 | 2021-07-28 | Bachem Holding AG | Purification of glucagon-like peptide 1 analogs |
| US12269844B2 (en) | 2019-03-25 | 2025-04-08 | Scinopharm Taiwan, Ltd. | Process for purifying semaglutide and liraglutide |
| TWI738260B (zh) | 2019-03-25 | 2021-09-01 | 台灣神隆股份有限公司 | 純化利拉魯肽之方法 |
| US11022585B2 (en) | 2019-06-09 | 2021-06-01 | Dionex Corporation | Methods and systems for optimizing buffer conditions with liquid chromatography |
| KR102691149B1 (ko) | 2021-01-20 | 2024-08-05 | 바이킹 테라퓨틱스 인코포레이티드 | 대사 및 간 질환 치료를 위한 조성물 및 방법 |
| CN115703825B (zh) * | 2021-08-17 | 2026-01-02 | 派格生物医药(杭州)股份有限公司 | 艾塞那肽变体及其聚乙二醇缀合物的制备方法 |
| US12421282B2 (en) | 2021-09-15 | 2025-09-23 | Viking Therapeutics, Inc. | Compositions and methods for the treatment of metabolic and liver disorders |
| CN114656550A (zh) * | 2021-12-28 | 2022-06-24 | 深圳翰宇药业股份有限公司 | 一种利拉鲁肽/索马鲁肽的纯化方法及应用 |
| WO2024147150A1 (en) * | 2023-01-02 | 2024-07-11 | Zelle Biotechnology Pvt. Ltd. | Chromatographic detection, estimation and separation of amino acids in hydrolysates of monoclonal antibodies |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4028120C2 (de) * | 1990-09-05 | 1996-09-19 | Hoechst Ag | Verfahren zur Reinigung von Insulin und/oder Insulinderivaten |
| US5424286A (en) | 1993-05-24 | 1995-06-13 | Eng; John | Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same |
| US6767887B1 (en) | 1996-06-05 | 2004-07-27 | Roche Diagnostics Gmbh | Exendin analogues, processes for their preparation and medicaments containing them |
| CA2264243C (en) * | 1996-08-30 | 2004-10-05 | Novo Nordisk A/S | Glp-1 derivatives |
| EP1076066A1 (en) | 1999-07-12 | 2001-02-14 | Zealand Pharmaceuticals A/S | Peptides for lowering blood glucose levels |
| JP2007526235A (ja) | 2003-08-21 | 2007-09-13 | ノボ ノルディスク アクティーゼルスカブ | グルカゴン様ペプチドの精製 |
| CN100535007C (zh) * | 2003-08-21 | 2009-09-02 | 诺沃挪第克公司 | 胰高血糖素样肽的纯化 |
| WO2007071768A1 (en) | 2005-12-23 | 2007-06-28 | Novo Nordisk A/S | Purification of proteins using preparative reverse phase chromatography (rpc) |
| WO2007071767A1 (en) | 2005-12-23 | 2007-06-28 | Novo Nordisk Health Care Ag | Purification of vitamin k-dependent polypeptides using preparative reverse phase chromatography (rpc) |
-
2011
- 2011-03-01 EP EP11705589A patent/EP2542565A1/en not_active Withdrawn
- 2011-03-01 US US13/580,204 patent/US9422330B2/en not_active Expired - Fee Related
- 2011-03-01 WO PCT/EP2011/052964 patent/WO2011107447A1/en not_active Ceased
- 2011-03-01 JP JP2012555389A patent/JP5992836B2/ja not_active Expired - Fee Related
- 2011-03-01 CN CN2011800118239A patent/CN102770440A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013521485A5 (enExample) | ||
| JP5992836B2 (ja) | ペプチドを精製するための分取ｒｐ−ｈｐｌｃ法 | |
| JP2012018171A5 (enExample) | ||
| FI3461261T3 (fi) | Yksiketjuisen vaihtelevan fragmentin sisältäviä cd3:a sitovia proteiineja | |
| JP2015071629A5 (enExample) | ||
| JP2013530156A5 (enExample) | ||
| JP2013503877A5 (enExample) | ||
| JP2016526909A5 (enExample) | ||
| ATE473438T1 (de) | Zuführung von molekülen an eine lipiddoppelschicht | |
| EP2125861B1 (en) | Method of purifying apolipoprotein a-1 | |
| WO2006032436A3 (en) | Use of microproteins as tryptase inhibitors | |
| JP2017512063A5 (enExample) | ||
| AR092076A1 (es) | Proteinas homodimericas | |
| WO2018018011A3 (en) | Methods of purifying fc-containing proteins | |
| JP2016530533A5 (enExample) | ||
| JP2015509091A5 (enExample) | ||
| JP2013501773A (ja) | クロマトグラフィーの方法およびその精製化合物 | |
| CN101981048A (zh) | 纯化肽的方法 | |
| EP3116527A1 (fr) | Procédé de préparation de protéines plasmatiques humaines | |
| CN103080128A (zh) | Glp-1类似物的反相hplc纯化 | |
| MX342922B (es) | Purificacion de insulina. | |
| Ghosh et al. | Purification of humanized monoclonal antibody by hydrophobic interaction membrane chromatography | |
| JP2019514399A5 (enExample) | ||
| HRP20171966T1 (hr) | Postupak za proizvodnju rekombinantnih proteina s niskim razinama dhna (1,4-dihidroksi-2-naftoata) | |
| US10155799B2 (en) | Chromatography process for purification of insulin and insulin analogs |